Table.
Clinical Information of Patient Samples Used for all In Vitro Studies
| Age (y) | Sex | CAS | Smoker | Duration of GO (y) | Proptosis R/L (mm) | Surgery Performed |
|---|---|---|---|---|---|---|
| GO patients | ||||||
| 44 | F | 0/7 | N | 11 | 21/21 | Decompression |
| 61 | F | 1/7 | N | 2 | 23/23 | Decompression |
| 45 | F | 0/7 | N | 4 | 26/26 | Decompression |
| 69 | M | 1/7 | Y | 1.8 | 19/19 | Decompression |
| 21 | F | 0/7 | N | 8 | 22/22 | Decompression |
| 29 | M | 0/7 | Y | 4 | 23.5/23.5 | Decompression |
| 54 | M | 4/7 | Y | 0.5 | 18/19 | Decompression |
| Non-GO control subjects | ||||||
| 23 | M | N/A | N | N/A | N/A | Evisceration |
| 75 | M | N/A | N | N/A | N/A | Evisceration |
| 35 | F | N/A | Y | N/A | N/A | Orbital wall fracture |
| 44 | F | N/A | N | N/A | N/A | Orbital wall fracture |
| 47 | F | N/A | N | N/A | N/A | Orbital wall fracture |
CAS, clinical activity scores; Y, yes; N, No; N/A, not applicable; F, female; M, male; R, right eye; L, left eye.